Low‐level light emitting diode therapy promotes long–term functional recovery after experimental stroke in mice. Issue 12 (2nd May 2017)
- Record Type:
- Journal Article
- Title:
- Low‐level light emitting diode therapy promotes long–term functional recovery after experimental stroke in mice. Issue 12 (2nd May 2017)
- Main Title:
- Low‐level light emitting diode therapy promotes long–term functional recovery after experimental stroke in mice
- Authors:
- Lee, Hae In
Lee, Sae‐Won
Kim, Nam Gyun
Park, Kyoung‐Jun
Choi, Byung Tae
Shin, Yong‐Il
Shin, Hwa Kyoung - Other Names:
- Luo Qingming guestEditor.
- Abstract:
- Abstract: We aimed to investigate the effects of low‐level light emitting diode therapy (LED‐T) on the long‐term functional outcomes after cerebral ischemia, and the optimal timing of LED‐T initiation for achieving suitable functional recovery. Focal cerebral ischemia was induced in mice via photothrombosis. These mice were assigned to a sham‐operated (control), ischemic (vehicle), or LED‐T group [initiation immediately (acute), 4 days (subacute) or 10 days (delayed) after ischemia, followed by once‐daily treatment for 7 days]. Behavioral outcomes were assessed 21 and 28 days post‐ischemia, and histopathological analysis was performed 28 days post‐ischemia. The acute and subacute LED‐T groups showed a significant improvement in motor function up to 28 days post‐ischemia, although no brain atrophy recovery was noted. We observed proliferating cells (BrdU + ) in the ischemic brain, and significant increases in BrdU + /GFAP +, BrdU + /DCX +, BrdU + /NeuN +, and CD31 + cells in the subacute LED‐T group. However, the BrdU + /Iba‐1 + cell count was reduced in the subacute LED‐T group. Furthermore, the brain‐derived neurotrophic factor (BDNF) was significantly upregulated in the subacute LED‐T group. We concluded that LED‐T administered during the subacute stage had a positive impact on the long‐term functional outcome, probably via neuron and astrocyte proliferation, blood vessel reconstruction, and increased BDNF expression.Picture : The rotarod test for motor coordination showedAbstract: We aimed to investigate the effects of low‐level light emitting diode therapy (LED‐T) on the long‐term functional outcomes after cerebral ischemia, and the optimal timing of LED‐T initiation for achieving suitable functional recovery. Focal cerebral ischemia was induced in mice via photothrombosis. These mice were assigned to a sham‐operated (control), ischemic (vehicle), or LED‐T group [initiation immediately (acute), 4 days (subacute) or 10 days (delayed) after ischemia, followed by once‐daily treatment for 7 days]. Behavioral outcomes were assessed 21 and 28 days post‐ischemia, and histopathological analysis was performed 28 days post‐ischemia. The acute and subacute LED‐T groups showed a significant improvement in motor function up to 28 days post‐ischemia, although no brain atrophy recovery was noted. We observed proliferating cells (BrdU + ) in the ischemic brain, and significant increases in BrdU + /GFAP +, BrdU + /DCX +, BrdU + /NeuN +, and CD31 + cells in the subacute LED‐T group. However, the BrdU + /Iba‐1 + cell count was reduced in the subacute LED‐T group. Furthermore, the brain‐derived neurotrophic factor (BDNF) was significantly upregulated in the subacute LED‐T group. We concluded that LED‐T administered during the subacute stage had a positive impact on the long‐term functional outcome, probably via neuron and astrocyte proliferation, blood vessel reconstruction, and increased BDNF expression.Picture : The rotarod test for motor coordination showed that acute and subacute LED‐T improves long‐term functional recovery after cerebral ischemia. Abstract : This study aimed to investigate the effects of low‐level light emitting diode therapy (LED‐T) on the long‐term functional outcomes after cerebral ischemia, and the optimal timing of LED‐T initiation for achieving suitable functional recovery. we clearly found that LED‐T administered during the subacute stage had a positive impact on the long‐term functional outcome, probably via neuron and astrocyte proliferation, blood vessel reconstruction, and increased brain‐derived neurotrophic factor expression. … (more)
- Is Part Of:
- Journal of biophotonics. Volume 10:Issue 12(2017)
- Journal:
- Journal of biophotonics
- Issue:
- Volume 10:Issue 12(2017)
- Issue Display:
- Volume 10, Issue 12 (2017)
- Year:
- 2017
- Volume:
- 10
- Issue:
- 12
- Issue Sort Value:
- 2017-0010-0012-0000
- Page Start:
- 1761
- Page End:
- 1771
- Publication Date:
- 2017-05-02
- Subjects:
- Functional recovery -- focal cerebral ischemia -- post-stroke -- BDNF -- neurotrophic factor -- photostimulation
Photonics -- Periodicals
Optical materials -- Periodicals
Optics -- Periodicals
Medical instruments and apparatus -- Periodicals
621.3605 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1864-0648 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1002/jbio.201700038 ↗
- Languages:
- English
- ISSNs:
- 1864-063X
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 5432.xml